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Introduction
The question of whether extrinsic signals, in particular cytokines, have a deter-
ministic role in lineage commitment of hematopoietic stem and progenitor cells has
been much debated. It is difficult to distinguish a definite role in commitment from
the well-characterized roles of cytokines in promoting proliferation and survival.
Recent work has provided strong evidence that lineage commitment of granulo-
cyte/monocyte progenitors (GMP) to granulocytes or macrophages can be specified
by the appropriate colony stimulating factor (CSF)1-3 but it is less clear whether
cytokines can control the lineage restriction of less mature stem and progenitor
cells.4,5 Common myeloid progenitors (CMPs) are immature hematopoietic progen-
itors that become restricted to either the erythroid lineage as megakaryocyte/ery-
throid progenitors (MEP), giving rise to red blood cells and megakaryocytes/
platelets, or the myeloid lineage as GMP, giving rise to neutrophils, eosinophils,
mast cells and macrophages. Mutations in regulators of lineage commitment from
CMP are often found in leukemia,6-9 highlighting the importance of understanding
this key regulatory event. 
The erythroid master regulator erythropoietin (epo) is fundamental to the control
of both homeostatic and stress erythropoiesis.10 Erythroid cell proliferation is
dependent on epo during the early S phase of the second colony forming unit-ery-
throid (CFU-E) division, coincident with the appearance of the erythroid marker
glycophorin A (GPA).11,12 Epo is also required for erythroid precursor cell survival
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through signal transducer and activator of transcription
(Stat-5) mediated activation of the apoptotic inhibitor B-
cell lymphoma-extra large (Bcl-XL).13 However, the role of
epo in controlling proliferation, maturation and survival of
the earliest erythroid progenitors is not completely under-
stood. In vivo, epo is essential from the CFU-E stage
onward as mutants defective for epo or epo receptor do
not produce mature red cells.14 Such mutants are able to
produce both early and late erythroid progenitors, burst
forming unit-erythroid (BFU-E) and CFU-E, respectively,
suggesting that epo signaling is not absolutely required for
erythroid commitment. However, a recent study has sug-
gested that high levels of epo can bias commitment
toward the erythroid lineage over the myeloid lineage
both in vivo and in vitro.15 To clarify these apparently con-
tradictory findings on the role of epo in lineage commit-
ment and erythropoiesis, we have determined the effect of
epo on the kinetics of proliferation and lineage restriction
during the maturation from CMP to MEP.
Population dynamics of hematopoietic culture is a com-
plex output generated by the interplay of proliferation,
maturation and cell death. Proliferation and cell death can
be followed directly using the carboxyfluorescein succin-
imidyl ester (CFSE) division-tracking dye and Annexin
V/propidium iodide staining, respectively, but maturation
associated with lineage restriction can only be analyzed
indirectly as a measure of the number of mature cells that
arise in culture which cannot be accounted for by prolifer-
ation or death. To disentangle the individual contributions
of these different cell behaviors, we have developed a
mathematical model of the early stages of erythroid cul-
ture during which cells become committed to the
megakaryocyte/erythroid lineage.
Mathematical models have been developed as tools to
assist in the analysis of population dynamics during
hematopoiesis,16-19 and to determine the transcription fac-
tor regulatory interactions that control hematopoietic dif-
ferentiation pathways.20 To understand how proliferation
integrates with lineage commitment and impacts on the
overall population dynamics, a number of mathematical
approaches for cell division have also been proposed, tak-
ing advantage of CFSE division-tracking. In particular, the
Smith-Martin model that takes into account progression
of cells through the cell cycle, has been successfully used
to predict and model population dynamics of in vitro ery-
thropoiesis.21-25
We have combined immunophenotyping, proliferation
analysis and cytokine dependence to refine the analysis of
early erythroid culture of CD34+ cells isolated from human
peripheral blood (PB). Isolated PB CD34+ cells are CMP,
and the appearance of detectable surface levels of the ery-
throid marker CD36 is the earliest identifier of progenitors
restricted to the megakaryocyte/erythroid lineage.26
Interestingly, CMP give rise to MEP independently of cell
division in erythroid culture and most of the starting CMP
become lineage-restricted prior to the onset of prolifera-
tion. We have developed an adaptation of the Smith-
Martin mathematical model that describes the population
dynamics of erythroid culture during lineage restriction
from CMP to MEP. The model suggests that cells become
responsive to epo as soon as they are committed to the
megakaryocyte/erythroid lineage, but epo does not con-
trol lineage restriction. 
Methods
Antibodies and reagents
Antibodies used were CD34-BV421, CD36-APC, CD90-PE,
CD123-PE/Cy5, CD38-APC/Cy7, CD135-PE and CD45RA-
BV421 (Biolegend) and CD36-PE, CD45-APC/Vio770, CD235
(GPA)-APC, CD61-APC/Vio770 (Miltenyi Biotec). AnnexinV-
BV421 (Biolegend) was used for analysis of dying cells. Monastrol
(Merck Chemicals Ltd, UK) was used at 100 mM to block cells in
M phase of the cell cycle.
Erythroid culture
Peripheral blood mononuclear cells (PBMCs) were isolated from
leukocyte cones by density purification over Histopaque (Sigma)
from healthy donors with informed consent. Isolated cells were
cultured in erythroid medium (EM); Stem Span (Stem Cell
Technologies) + 10 ng/mL stem cell factor (SCF) (for Day 0 to Day
4) and 50 ng/mL (for Day 5 to Day 11), 40 ng/mL insulin-like
growth factor1 (IGF-1), 1 ng/mL interleukin-3 (IL-3), 1 mM dexam-
ethasone and with or without 2 U/mL epo  (details in Online
Supplementary Methods). Research was reviewed and approved by
Southmead and Bristol Research Ethics Committee Centre
(08/H0102/26 and 12/SW/0199, respectively). 
Cell cycle analysis
K562 cells were grown in Iscove modified Dulbecco medium +
20% fetal calf serum, fixed in ice cold 70% ethanol and rehydrated
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Table 1. Parameters of the mathematical model. Symbols and physiological meaning of the parameters used in the full (37 parameter) mathe-
matical model, and (column 3) their values in the simplified (20 parameter) model.
Parameter Description Simplification
αi Proliferation rate: CMP generation i≥0
δi Proliferation rate: MEP generation i≥0
mI, mF Maturation rates (initial, final): CMP to MEP generation 0
mI Maturation rate: CMP to MEP generation i>1 mi ≥1= mF
mi Logistic function parameters (bias, decay rate): CMP proliferation generation 0 Fixed by dataset A
Qδ, Rδ Logistic function parameters (bias, decay rate): MEP proliferation generation 0 Fixed by dataset A
Qm, Rm Logistic function parameters (bias, decay rate): CMP to MEP maturation generation 0 Fixed by dataset A
tC,tM Proliferation initiation delays: CMP, MEP generation 0 Fixed by dataset A
Di ‘b’ compartment delay: CMP generation i≥1 Di=D
Gi ‘b’ compartment delay: MEP generation i≥1 Gi≥4=G3
in phosphate buffered saline (PBS). Fixed cells were stained in PBS
(Sigma) + 0.1% Triton X-100 + 10 mg/mL propidium iodide + 100
mg/mL RNase and analyzed on the MACSQuant VYB flow
cytometer.
Flow cytometry and fluorescence assisted cell sorting
Flow cytometry and fluorescence assisted cell sorting (FACS)
was used to analyze cells stained with anti-human-specific anti-
bodies on the MACSQuant and post-acquisition analysis was car-
ried out with FlowJo v.7.6.5 for proliferation analysis and FlowJo
v.X0.7 for all other analysis (details in Online Supplementary
Methods).
CFSE tracking
CD34+ cells were labeled on the day of isolation with CFSE
(Biolegend) at 2 mM in PBS for 15 min at 37°C. Excess CFSE was
quenched by incubating in Stem span + 10% fetal calf serum for 5
min at 37°C. Cells were washed in PBS and transferred into EM at
a density of 2x104 cells/mL in multi-well dishes so that each time
point was taken from a separate well. For extended cultures
beyond Day 4, cells were fed by 1:2 partial medium change into
EM with 100 ng/mL SCF.
Results
CD36 expression marks megakaryocyte/erythroid
restricted progenitors 
At the time of isolation, CD34+ cells from human
PBMNC, are 85%
CD34+CD38+IL3Rα−CD45RA−CD90−CD45lo (Figure 1A),
previously defined as CMP27,28 and 15% of CD34+ cells are
CD34+CD45lo IL−3Rlo CD38+CD90− CD45RA+, GMP as
previously described,29,30 which do not persist in erythroid
culture (Online Supplementary Figure S1). CD34+ cells cul-
tured in serum-free medium supplemented with appro-
priate cytokines including SCF, IL-3 and epo mature into
erythroid cells. The appearance of erythroid precursors
and erythroblasts is easily detected by the appearance of
the erythroid marker GPA (Ter119) at Day 7 to Day 10 of
culture, depending on conditions. To identify the less
mature erythroid progenitors, MEP, at the point of lineage
restriction from CMP, prior to GPA expression, we exam-
ined the change during culture of the previously defined
markers interleukin-3 receptor (IL-3R/CD123) and Fms-
like tyrosine kinase 3 (Flt-3/CD135), which are present at
low levels on CMP and GMP and absent on MEP isolated
from human bone marrow and cord blood.27,31,32 Surface
levels of both markers increase over the first two days in
culture and then decrease to Day 4 on the bulk popula-
tion, so they do not provide useful markers for early line-
age restriction in erythroid culture (Figure 1B). The ery-
throid marker CD36 was originally identified as a cell sur-
face marker of erythroblasts33 and later shown to be
detectable prior to the appearance of the erythroid differ-
entiation marker GPA.34 At isolation, PB CD34+ cells do
not express CD36, but give rise to CD34+CD36+ cells
within the first few days of culture (Figure 1C). To deter-
mine whether surface expression of CD36 marks the lin-
eage restriction event, CD34+ cells were cultured for 2-4
days and then separated by FACS into CD34+CD36− and
CD34+CD36+ populations. CD34+CD36− cells give rise to
both erythroid (burst forming unit-erythroid, BFU-E) and
myeloid [colony forming unit-granulocyte/monocyte
(CFU-GM)] colonies in methylcellulose, indicating these
cells are the CMP population. CD34+CD36+ cells give rise
only to BFU-E (Figure 2A). BFU-E colonies contain small
numbers of megakaryocytes (Figure 2B) consistent with
the assignment of CD34+CD36+ cells as bipotent MEPs.
This is further supported by the finding that CD34+CD36+
cells are CD61lo (Figure 2C, population I,) reflecting
megakaryocyte potential.36
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Table 2. Parameter values of the mathematical model. 
α0 α1 α2 α3 α4 α5 mI mf
Dataset A 0.018 0.054 0.108 0.181 0.213 0.195 0.016 0.004
Dataset B 0.023 0.066 0.120 0.183 0.200 0.185 0.017 0.002
Dataset C 0.014 0.045 0.098 0.198 0.264 0.299 0.025 0.003
Dataset D 0.012 0.042 0.086 0.174 0.255 0.269 0.020 0.005
δ0 δ1 δ2 δ3 δ4 δ5
Dataset A 0.128 0.123 0.119 0.127 0.129 0.110
Dataset B 0.143 0.150 0.124 0.125 0.121 0.125
Dataset C 0.118 0.121 0.158 0.181 0.279 0.269
Dataset D 0.088 0.114 0.119 0.146 0.206 0.199
tC tM D G1 G2 G3
Dataset A 30.394 27.705 9.800 14.549 9.817 8.017
Dataset B 31.119 27.800 9.602 13.892 10.688 8.264
Dataset C 29.708 26.279 10.742 14.599 10.540 10.316
Dataset D 28.841 25.765 10.623 12.453 9.521 10.893
δ6 δ7 δ8 δ9 δ10 δ11 δ12 δ13
Dataset E 0.314 0.35 0.386 0.422 0.458 0.494 0.53 0.566
Dataset F 0.234 0.259 0.284 0.309 0.334 0.359 0.384 0.409
Rows 1, 5 and 9: parameters fitted using dataset A, used in simulations shown in Figure 5A-D, and Online Supplementary Figures S4 and S5 (red lines). Rows 2, 6 and 10: re-identified
parameters used for validation (dataset B), simulation shown in Online Supplementary Figure S5 (black lines). Rows 3, 7 and 11: fitted parameters on the control data sets (dataset
C), simulations shown in Figure 6C, E anf F,  and Online Supplementary Figure S6A-C. Rows 4, 8 and 12: fitted parameters on the minus epo data sets (dataset D), simulations shown
in Figure 6C, E and F,  and Online Supplementary Figure S6 A-C. Rows 13 and 14: parameters 6-13 are the extrapolated proliferation rates used to predict the MEP cell counts from
90 h to 186 h (Figure 6E, datasets E and F, plus and minus epo, respectively), calculated by assuming a linear relationship between MEP proliferation rates above. Proliferation rates
are divisions per hour and maturation rates are transitions per hour.
Maturation of CMP to MEP is independent of cell 
division
Previous work had suggested that PB CD34+ cells divided
asymmetrically dependent on unequal distribution of the
determinants Notch and Numb.37 One possible explanation
for the observed population dynamics of erythroid culture,
in particular the retention of CMP concurrent with MEP
production (Online Supplementary Figure S2), is that CMP
might divide asymmetrically to produce 1 MEP and 1 CMP.
To test this, we first examined whether maturation of
CMP to MEP was coincident with cell division by follow-
ing proliferation of PB CD34+ cells by CFSE tracking. Cells
were CFSE-labeled at the time of isolation and the number
of cells in each generation was determined separately for
CMP and MEP by gating on CD36. After 24 h in culture, all
cells in both CMP and MEP populations remain in genera-
tion 0 [G(0)] and do not progress to G(1) until the second
day of culture, indicating a lag phase for both CMP and
MEP from the time of isolation to the initiation of prolif-
eration between Days 1 and 2 (Figure 3A, top panels).
Maturation of CMP to MEP begins immediately, as is clear
from the emergence of CD36+ MEP on Day 1, before the
appearance of G(1) cells (Figure 3B). This indicates that
maturation does not require cell division, at least for G(0)
CMP, and rules out the possibility that MEP arise from
CMP by asymmetric division. This was confirmed by
demonstrating that inhibiting cell cycle progression with
Monastrol does not block maturation of CD34+ cells to
MEP (Online Supplementary Figure S3). 
By Day 2, 75% MEP and 24% CMP have undergone a
Modeling lineage commitment in erythroid culture
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Figure 1. Immunophenotyping of peripheral blood (PB) CD34+ cells in erythroid culture. (A) Surface expression of CD34, CD45, CD38, IL-3R (CD123), CD45RA and
CD90 on PB CD34+ cells on the day of isolation. All populations were gated first on Propidium iodide incorporation and scatter properties. Cells were gated for CD34+
and CD45lo (left panel) prior to analysis of CD38 and CD90. IL-3R and CD45RA were analyzed on the total live population. Gates were set with isotype controls. (B)
Surface expression of IL-3R and Flt3 on CD34+ cells cultured in EM for four days. Stained cells in blue and isotype controls in orange. Expression of both markers
increases in the total population during the first three days of culture and then decreases. (C) Surface expression of CD36 over four days of culture demonstrating
that CD36− and CD36+ cells comprise distinct populations. Stained cells in blue and isotype controls in orange.
A
B
C
first division and are in G(1) (Figure 3A). Overall, CMP
proliferation is heterogeneous with an even distribution of
cells over 5 generations from G(0-4). By contrast, all of the
MEP cells divide within the first three days as indicated by
the absence of cells in G(0) and, by Day 4, 84% MEP are
found in 3 generations G(3-5) with a distinct peak (35%)
in G(4), suggesting a largely synchronously proliferating
population (Figure 3C). 
To determine whether cell death has a significant effect
on population dynamics, dying and dead cells were quan-
tified over a 4-day time course by Annexin V staining and
Propidium Iodide incorporation, respectively. The total
number of dead cells was insignificant compared to live
cells (Figure 3D). Annexin V staining was undetectable.
Mathematical model of population dynamics 
of erythroid culture
Understanding the role of extrinsic factors on CMP to
MEP maturation and progenitor proliferation requires a
means of measuring the relative parameters independent-
ly, which is not possible using population dynamics alone.
Instead, we have developed a mathematical model that
simulates the population dynamics, in terms of CMP and
MEP numbers, dependent on a set of parameters (Table 1)
derived from our experimental data, which include total
cell number, CMP:MEP ratio and cell division by CFSE
tracking with sampling every eight hours during the first
four days of culture
Our model is an adaptation of the Smith-Martin model.
It separates the cell cycle into two distinct compartments
‘a’ and ‘b’, representing the G1 (‘a’) and the combined S, G2
and M phases (‘b’) of the cell cycle. We incorporated mat-
uration of CMP to MEP, as shown schematically in Figure
4A. Cells originate in the ‘a’ compartment, with their tran-
sition governed by a stochastic process. This gives rise to
rates αi and δi for generation i CMP and MEP cells, respec-
tively, transitioning to the ‘b’ compartment, and rate mi for
generation i CMP maturing to generation i MEP. Cells
remain in the ‘b’ compartment for a fixed time (Di and Gi
for CMP and MEP, respectively) before they divide and
then re-enter the ‘a’ compartment as a next generation cell.
In order to simplify the model whilst maintaining the
key dynamics that relate to lineage restriction, we made
the following assumptions based on data presented in
Figure 3: 1) death rate plays an insignificant role over the
time course; 2) cell maturation initiates prior to the onset
of CMP and MEP proliferation and, thus, does not require
transition through the cell cycle; 3) GMP are excluded
from the analysis as this population does not contribute
significantly to the population dynamics in the first four
days of culture (Online Supplementary Figure S1). The CMP
and MEP populations in each generation evolve according
to a set of coupled delay differential equations (Figure 4B).
To account for the observation that maturation initiates
prior to the onset of proliferation (Figure 3B), we allowed
the first generation proliferation and maturation rates to
be time dependent. Constant rates for proliferation and
maturation in G(0) do not provide a good qualitative or
quantitative match to data, while piecewise constant rates
(a single step function for each rate) substantially improve
D. Ward et al.
290 haematologica | 2016; 101(3)
Figure 2. Surface expression of CD36 marks the transition from
CMP to MEP in erythroid culture. (A) CD34+ cells cultured in EM for
two or four days were sorted by FACS into CD34+CD36− and
CD34+CD36+ populations. Sorted cells were cultured in methylcel-
lulose for two weeks and colonies enumerated. Results are from 3
independent experiments, 2 tests per experiment. Error bars are
standard deviation. (B) Cytospin from an individual erythroid
colony stained with May Grünwald/Giemsa showing a megakary-
ocyte (M) with multiple nuclei and surrounding erythroblasts (E).
(C) The megakaryocyte marker CD61 is absent on cells at isolation
(data not shown) and heterogeneous at Day 2 with low expression
on CD36+ MEP (population I, 46% CD34+CD36+CD61lo/−) and large-
ly absent on CD36− CMP (population II, 37% CD34+CD36− CD61−).
There is a small population of CD61− cells (population III, 17%
CD34+CD36+CD61−) which may be megakaryocyte progenitors
directly descended from CMP as previously described for mouse
multipotent progenitors.47
A
B C
the fit. To maintain physiological plausibility, we model
G(0) rates as smoothed step functions, in the form of gen-
eralized logistic functions (Figure 4C).
We then used optimization routines to find the set of
parameters that minimizes the root mean square error
(RMSE) to the experimental data (CFSE tracking) (see
Online Supplementary Methods). The system was fitted to
experimental data (Online Supplementary Table S1, dataset
A) initially in the most general case, where all 37 parame-
ters are generation dependent (Online Supplementary Table
S2). This provided insight as to the system behavior and
allowed us to make simplifications with no significant
increase in RMSE (see Online Supplementary Methods), and
reduce the system to 20 parameters: 12 proliferation rates
(α(0-5), δ(0-5)), 2 maturation rates (mI, mF), 4 compartmental
delays (D, G(1-3)), and 2 proliferation initiation delays (tC, tM). 
We observed very good quantitative agreement
between model and experiment for all generations (Figure
5A and B and Online Supplementary Figure S4A and B). To
quantify the experimental error, standard deviation was
calculated and normalized over total cell counts (shaded
regions in Figure 5B). The standard deviation found within
the experimental data was 222.44 (3.07%) for CMP, and
279.46 (2.75%) for MEP. The RMSE error between exper-
Modeling lineage commitment in erythroid culture
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Figure 3. CFSE tracking highlights key features of early erythroid culture. CD34+ cells were labeled with CFSE on the day of isolation and cultured in EM for four days.
(A) Cells were gated on CD34+CD36− (CMP) or CD34+CD36+ (MEP) and generation occupancy was determined by flow cytometry. Numbers above peaks indicate gen-
eration. After one day in culture, cells have not divided and all cells are in G(0), (top panels). Proliferation begins for CMP and MEP between Day 1 and Day 2 as demon-
strated by the appearance of a peak at half the mean fluorescence intensity (MFI) of the original peak (G(0) MFI=63000 for G(0) and MFI=34000 for G(1)). This gen-
eration analysis was done manually in FlowJo vX0.7. (B) CD36 staining on Day 1 of the same cells as shown in the left panels demonstrates the appearance of CD36+
cells prior to the onset of proliferation. (C) Generational occupancy at Day 4 shows that MEP proliferation is more synchronized than CMP with 84% MEP within 3 gen-
erations, G(3-5), and 85% CMP evenly distributed in 5 generations, G(0-4). (D) Cell death is insignificant during the first four days of culture as measured by propidium
iodide staining to identify dead cells (gray) as compared to live cells (green). Error bars are standard deviation.
A B
C
D
imental data and model predictions for optimal parameter
values (Figure 5B) was 101.02 (1.38%) for CMP and 138.29
(1.85%) for MEP. Table 2 shows the rates (divisions per
hour) and delays (hours) obtained from the optimization
algorithm.
The model was validated using a second, independent
experimental data set (dataset B) in two different ways
(Online Supplementary Methods and Online Supplementary
Figure S5), and indicated high confidence in the model and
parameter values. Further in silico experiments were con-
ducted on an extensive set of simulated data, confirming
robustness of the parameter identification methods used
(Online Supplementary Methods and Online Supplementary
Table S3).
The identified parameters for dataset A (Table 2) show
that the average MEP proliferation rate (δ) is 0.12 divisions
per hour, and that this rate does not vary greatly from the
onset of proliferation to Day 4 (Figure 5C). The rate of
proliferation of CMP cells is initially 10% of the prolifera-
tion rate of MEP, and increases with each generation such
that CMP transit from G(5) to G(6) is approximately twice
the average MEP rate (Figure 5C). The maturation rate for
G(0) (m0(t)) decreases over time, from 0.016 to 0.004 transi-
tions per hour (Figure 5D). Importantly, the maturation
rate, even at the beginning of the culture when it is at its
highest, is an order of magnitude smaller than the MEP
proliferation rate. These parameters show important fea-
tures of the relative contributions of proliferation and mat-
uration to overall population dynamics at different stages
in the culture: while maturation plays a crucial role at the
beginning, proliferation is the main effector of later culture
stages.
The role of epo in maturation from CMP to MEP
To investigate a possible role for epo in the earliest
stages of erythropoiesis in vitro, CD34+ cells were isolated
and cultured under standard conditions or in the absence
of epo. After one day in culture, prior to the onset of pro-
liferation, 20% CMP have matured to MEP under both
conditions (Figure 6A), suggesting that CMP to MEP tran-
sition during the first 24 h is not responsive to epo in G(0).
However, over nine days in culture, there is a dramatic dif-
ference in the number of MEP in control and minus epo
cultures and by Day 9 there is over 20 times more MEP
produced in cultures with epo (Figure 6B). 
The lower MEP production in the absence of epo could
be due to defects in maturation, proliferation, or both. To
resolve the individual effects of epo on maturation and
proliferation, we used the model to fit parameters from
generational CMP and MEP counts of 4-day cultures with
and without epo (datasets C and D). The results are
shown in Figure 6C and Online Supplementary Figure S6A
and B. Parameter fitting shows that the proliferation rate
of MEP (δ) is 21% lower in the absence of epo, whereas
there is less than 10% difference in proliferation rates of
CMP (α) (Table 2). The traces from CFSE tracking also sup-
port this result in that a distinct delay in generation pro-
gression for MEP is detectable in cultures without epo
(Figure 6D). Also, CFSE tracking shows no significant
effect of epo on CMP generation occupancy (Figure 6D);
this result, taken together with insignificant change in pro-
liferation rate of CMP (Table 2), indicates that CMP prolif-
eration is not epo-sensitive. Model validation, using fitted
parameters for δ to reproduce MEP amplification in 2 addi-
tional experimental datasets (Online Supplementary Table
D. Ward et al.
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Figure 4. Mathematical model of the system. (A)
Schematic diagram of erythroid cell culture. The cell
cycle is modelled as a 2-stage process, composed of
compartments ‘a’ approximating the G1 phase of the
cell cycle, and ‘b’ approximating the S/G2/M phases.
CMP and MEP both originate in the ‘a’ compartment.
Their transition is governed by a stochastic process,
with rates 𝛼𝑖 and 𝛿𝑖 for generation 𝑖 CMP and MEP cells,
respectively, to transition to the ‘b’ compartment, and a
rate 𝜇𝑖 of maturing (transitioning) from CMP into same-
generation MEP cells. Cells remain in the ‘b’ compart-
ment for a fixed time (∆𝑖 and Γ𝑖 for CMP and MEP,
respectively) before they divide and then re-enter the ‘a’
compartment as a next generation cell. (B) The size of
the CMP and MEP populations in each generation at
each time point are given by 4 delay differential equa-
tions (DDEs) where 𝐶𝑖(𝑡) and 𝑀𝑖(𝑡) are the generational
populations of CMP and MEP, respectively. (C) G(0) pro-
liferation and maturation rates are time-dependent,
taking the form of generalized logistic functions, where
𝑃𝛼 is the maximum proliferation rate for G(0) CMP, 𝑃𝛿 is
the maximum proliferation rate for G(0) MEP, and 𝜇I and
𝜇F are the initial and final maturation rates for G(0). The
parameters 𝑄𝛼,𝑅𝛼,𝑄𝛿,𝑅𝛿,𝑄𝜇, 𝑅𝜇, 𝜏C and 𝜏M control the
dynamics of the generalized logistic functions and were
optimized for. Equations were solved using MATLAB®
solver dde23.48
A
B
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S1, datasets E and F), further supports this result (Online
Supplementary Figure S6C). 
We have used the parameters calculated from 4-day cul-
tures with and without epo to simulate MEP population
expansion to Day 8 (Table 2 and Figure 6E, datasets E and
F). For control cultures, there is good agreement between
the predicted cell numbers and experimental data. For cul-
tures without epo, there is good agreement for the first 5-
6 days (up to time 130 h in Figure 6E), and then the exper-
imental data show a significantly slower proliferation than
predicted. This suggests that there is a change in epo sen-
sitivity between Days 5 and 6, after which MEP proliferate
very slowly without epo.
The maturation rate for G(0) (m0(t) (Table 2) is not signif-
icantly different with or without epo (datasets C and D).
Although the final maturation rate is slightly higher in the
absence of epo, this cannot account for the decrease in
MEP formation, suggesting that epo effects on population
dynamics and MEP production are not mediated by
altered maturation rates. To determine whether epo con-
fers an erythroid bias, we used CFSE tracking to quantify
CMP maturation and showed that epo does not affect the
total number of CMP that mature to MEP (Figure 6F).
These results provide strong evidence that neither the rate
nor the bias of the CMP to MEP transition is influenced by
epo. 
Discussion
Understanding the fundamental mechanisms controlling
lineage commitment, proliferation and survival during
erythropoiesis is becoming an achievable goal thanks to
the advent of novel high throughput technologies to
explore the transcriptome,39-42 proteome43 and
epigenome.44,45 In order to maximize the specificity of the
information afforded by these techniques, it is essential to
start with well-defined populations. A recent report pro-
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Figure 5. Fitted model simulations provide proliferation and maturation parameters and recapitulate population dynamics. (A) Fitted model simulations (solid lines)
of CMP (left panel) and MEP (right panel) cell numbers in each generation. Experimental data (dataset A) are dashed lines, ± standard error (shaded regions). (B)
Model simulation of total CMP (left panel) and MEP (right panel) cell numbers using model derived parameters (solid lines) together with experimental data (dashed
lines) ± standard error (shaded regions). (C) Proliferation rates dataset A for CMP (α) in blue, and MEP (δ) in orange, as divisions per hour over the first 5 generations.
(D) Changes for dataset A in maturation rate (m0) of G(0) CMP in the first 90 h of culture expressed as CMP to MEP transitions per hour. 
A
C
B
D
vided an excellent protocol to identify populations at dis-
tinct stages of erythroid differentiation,46 but early ery-
throid culture has proved more challenging. To achieve
this, it is necessary to measure the transition event under
experimental conditions where proliferation and survival
can be controlled and/or measured simultaneously. We
identified CD36 as a cell surface marker that distinguishes
CMP and MEP as distinct populations.
Identification of CD36 as an MEP marker provides a
powerful tool to investigate the influence of extrinsic fac-
tors on lineage restriction of CMP to MEP. Epo is essential
for steady-state and stress erythropoiesis and is used ther-
apeutically to increase red cell production in clinical ane-
mia. It is of considerable interest, therefore, to understand
the precise role of epo in hematopoiesis. There is a signif-
icant body of work demonstrating that an essential role of
epo is to promote proliferation of erythroid progenitors
and survival of differentiating erythroblasts.47,48 This raises
the question of whether epo acts on less mature progeni-
tors. Early work from Lodish et al.14 showed that epo and
the epo receptor are not required to generate early ery-
throid-specified progenitors in vivo, suggesting that epo
does not have an instructive role in early hematopoiesis.
On the other hand, a more recent study15 showed that
early progenitors are responsive to epo, and that high lev-
els of epo suppress GMP formation through transcription-
al reprogramming, both in vivo and in vitro. Interestingly,
this study showed that although there is a relative increase
in erythroid progenitors compared to non-erythroid pro-
genitors, the absolute number of erythroid progenitors is
not affected by high levels of epo in vivo. Our results using
mathematical modeling correspond well with these stud-
ies, demonstrating that the time-dependent maturation
rate of CMP is not affected by epo. Importantly, equal
numbers of CMP convert to MEP with and without epo,
further supporting the idea that epo does not bias CMP
commitment toward the erythroid lineage. Population
dynamics of cord blood CD34+ cells in erythroid culture
show similar dynamics to PB CD34+ cells (Online
Supplementary Figure S7) suggesting that these results are
likely to be applicable to CMP from other sources. This
provides validation for the proposed model in demonstrat-
ing consistency with in vivo data. 
It is important to note that, while our results clearly
indicate that the MEP population is homogeneous, the
CMP population behaves heterogeneously in terms of
proliferation. It is, therefore, possible that there is an earli-
er restricted progenitor within the CMP population that is
indistinguishable from other CMP using known markers.
Developing a transcriptomic fingerprint of CD34+CD36+
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Figure 6. MEP proliferation rate is epo-sen-
sitive but CMP maturation is independent
of epo. (A) Cell numbers for CMP and MEP
after one day in control (blue) and minus
epo (red) culture ± standard deviation.
Data are from 4 experiments, 3 samples
per experiment. (B) Relative difference in
MEP numbers in control and minus epo cul-
tures (fold difference = N. control/N. minus
epo MEP ± standard deviation) from 3
experiments. (C) Model fitting simulations
for control (blue) and minus epo (red) cul-
tures compared to experimental data from
datasets C and D (dots). Shaded regions
represent standard error in the experimen-
tal data. (D) CFSE in CMP and MEP after
four days in control culture (blue) or minus
epo (red). Traces from 3 samples are over-
laid. Generations 2, 3 and 5 are labeled.
(E) Extrapolation of MEP cell counts from
datasets E and F to Day 8 (186 h) using
best-fit parameters in Table 2 for both con-
trol and minus epo populations. Additional
proliferation rates (𝛿6−13) predicted by
assuming a linear relationship between the
optimized proliferation rates, found from
the Day 0–4 fitting for G(0) to G(5) MEP,
allowing us to extrapolate forward for G(6)
onwards. (F) Maturation over four days
expressed as percentage of CMP matured
from experimental data (circles) and model
predictions (lines). Experimental values
were calculated as the number of CMP tak-
ing into account cell division. CMP matured
= N. CMP in G(0) + sum over 6 generations
N. CMP G(i)/2i. Model predicted maturation
was tracked from all generations of CMP
throughout the simulations. 
A B C
D
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cells would allow us to investigate this possibility using
single cell analysis applied to the CMP population.
Although it is well established that epo is required for
proliferation of late erythroid progenitors, a possible influ-
ence of epo on earlier progenitors has not been described.
To test this, we determined the progenitor proliferation
rates using the model. This showed that, from the initial
stages of megakaryocyte/erythroid lineage commitment,
cells are epo responsive and proliferation is slower in the
absence of epo. By disentangling the independent contri-
butions of proliferation and maturation to population
dynamics, the model allowed a high-resolution quantifica-
tion of proliferation rate that revealed the sensitivity of
MEP to epo. This means of quantification will be highly
beneficial to the efforts to amplify erythroid cells in cul-
ture for the production of red cells for clinical transfusion;
a 4-5 day culture significantly decreases the cost and sim-
plifies screening of changes in culture conditions as com-
pared to end point analysis from 2-3 week cultures.
Model simulations using a proliferation rate derived
from the first four days of culture and extrapolating to
Day 8 show that the derived proliferation rate faithfully
reproduces the experimental data. This confirms the
power of the model to describe erythroid culture.
Interestingly, simulating MEP amplification to Day 8 in
the absence of epo using the proliferation rate derived
from the first four days of culture shows a marked change
after Day 5. This suggests that there are two MEP stages
with different epo sensitivity: an early stage (Days 1-4)
with a small increase in proliferation rate in response to
epo and a later stage (Days 4-8), which is increasingly
dependent on epo for proliferation. The increased resolu-
tion of cell behavior parameters given by the mathemati-
cal model provides a valuable tool to further investigate
both the mechanism of lineage restriction and prolifera-
tion behavior of hematopoietic progenitors in culture.
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